Cytogen싸이토젠
217330 · KOSDAQ · ₩217330 · 싸이토젠
₩2,475▲ ₩25 (1.02%)End-of-day · Oct 28, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 24.4% | 21.6% | 25.9% | 26.6% | 25.7% | 16.5% |
| Operating margin | −23.9% | −31.3% | −97.8% | −370.3% | −1,511.3% | −3,697.3% |
| Net margin | −38.5% | −47.4% | −156.9% | −495.2% | −2,467.4% | −3,125.1% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +5.1% | +138.8% | +242.6% | +318.6% | +118.7% | — |
| Operating income growth | +19.7% | +23.5% | +9.5% | −2.6% | +10.6% | — |
| Net income growth | +14.5% | +27.9% | −8.5% | +16.0% | −72.7% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | −30.6% | −29.3% | −33.6% | −53.4% | −131.0% | −47.2% |
| Return on assets | −18.0% | −18.3% | −23.3% | −27.3% | −38.8% | −19.6% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 62.2% | 72.9% | 48.1% | 39.5% | 628.8% | 141.3% |
| Net debt to equity | −27.5% | −43.1% | −56.4% | −72.1% | 174.7% | −28.5% |
| Current ratio | 749.3% | 293.1% | 1,019.7% | 521.1% | 57.1% | 641.8% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Cytogen / 싸이토젠 / 217330 / KRX:217330
Source: KRX statistical information